中仑新材料股份有限公司 2024 年度监事会工作报告 2024 年度，中仑新材料股份有限公司（以下简称"公司"）监事会严格按照 《公司法》《证券法》《深圳证券交易所创业板股票上市规则》《深圳证券交易 所上市公司自律监管指引第 2 号——创业板上市公司规范运作》等法律法规、规 范性文件及《公司章程》《监事会议事规则》等公司内部治理制度的相关规定， 以维护公司利益和股东利益为原则，勤勉尽责，积极列席董事会和股东大会，并 对公司重大事项的决策程序、合规性进行了核查，对公司财务状况和财务报告的 编制进行了审查，对公司董事、高级管理人员履职情况等进行监督。现将 2024 年度监事会工作情况报告如下： 一、2024 年度监事会召开情况 公司监事会由 3 名监事组成，其中职工代表监事 1 名，监事会的人数及人员 构成符合相关法律法规、规范性文件及《公司章程》的要求。2024 年，公司监事 会共召开 8 次会议，历次会议的召集和召开程序、出席会议人员比例、及表决程 序等均符合法律法规及《公司章程》《监事会议事规则》的有关规定，会议记录 完整规范，作出的会议决议合法有效，监事会不存在违反《公司法》及其他规定 行使职权的情况。公 ...

RSM 容诚 非经营性资金占用及其他关联资金 往来情况专项说明 中仑新材料股份有限公司 容诚专字[2025]361Z0136 号 容诚会计师事务所(特殊普通合伙) 中国 · 北京 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台（http://www.mof.gov.cn）"进行 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台（http://etc.mof.eov.cn） "进行 " " 关于中仑新材料股份有限公司 非经营性资金占用及其他关联资金往来情况专项说明 容诚专字[2025]361Z0136 号 中仑新材料股份有限公司全体股东: 我们接受委托,依据中国注册会计师审计准则审计了中仑新材料股份有限公 司(以下简称中仑新材公司)2024年12月31日的合并及母公司资产负债表,2024 年度的合并及母公司利润表、合并及母公司现金流量表和合并及母公司所有者权 益变动表以及财务报表附注，并于 2025 年 4 月 22 日出具了容诚审字 [2025]361Z0171 号的无保留意见审计报告。 根据中国证券监督管理委员会《上市公司监管指引第 8 号——上市公司资金 往来、对外担保的监管要求》的要求 ...

证券代码：301565 证券简称：中仑新材 公告编号：2025-013 中仑新材料股份有限公司 关于使用部分闲置募集资金进行现金管理的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 重要内容提示： 1.投资种类：现金管理品种为安全性高、流动性好的保本型现金管理产品（包 括但不限于通知存款、结构性存款、国债逆回购及银行等金融机构的保本型理财 产品等）。 2.投资金额：不超过人民币 1.35 亿元。 3.特别风险提示：本次使用闲置募集资金进行现金管理事项尚存在宏观经济 波动风险及投资收益不及预期等风险，敬请投资者注意投资风险。 中仑新材料股份有限公司（以下简称"公司"）于 2025 年 4 月 22 日召开了 第二届董事会独立董事专门会议 2025 年第一次会议、第二届董事会第八次会议、 第二届监事会第八次会议，分别审议通过了《关于使用部分闲置募集资金进行现 金管理的议案》，同意公司（含子公司，下同）使用不超过人民币 1.35 亿元（含 本数，下同）的暂时闲置募集资金进行现金管理，本次现金管理事项在公司董事 会审议权限内，无需提供公司股东大会审议。公司投资的 ...

证券代码：301565 证券简称：中仑新材 公告编号：2025-012 中仑新材料股份有限公司 关于召开 2024 年年度股东大会的通知 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 中仑新材料股份有限公司（以下简称"公司"）于 2025 年 4 月 22 日召开了 第二届董事会第八次会议，审议通过了《关于召开 2024 年年度股东大会的议案》， 定于 2025 年 5 月 15 日（星期四）14:30 召开 2024 年年度股东大会，本次会议 采取现场表决与网络投票相结合的方式召开，现将本次股东大会的有关事项公告 如下： 一、召开会议的基本情况 1、股东大会届次：2024 年年度股东大会 2、会议召集人：公司董事会 3、会议召开的合法、合规性：董事会召集召开本次股东大会会议符合《中 华人民共和国公司法》《中华人民共和国证券法》《深圳证券交易所创业板股票 上市规则》等有关法律、法规、规范性文件和《公司章程》等有关规定。 4、会议时间： （1）现场会议时间：2025 年 5 月 15 日（星期四）14:30 开始 （2）网络投票时间：2025 年 5 月 15 ...

证券代码：301565 证券简称：中仑新材 公告编号：2025-008 中仑新材料股份有限公司 第二届董事会第八次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 一、董事会会议召开情况 本议案尚需提交公司股东大会审议。 2、审议通过《关于公司<2024 年度总经理工作报告>的议案》 公司董事会听取了总经理颜艺林先生所作的《2024 年度总经理工作报告》， 认为 2024 年度公司管理层有效地执行了董事会、股东大会的各项决议，较好地 完成了公司 2024 年度经营目标。 2025 年 4 月 22 日，中仑新材料股份有限公司（以下简称"公司"）第二届 董事会第八次会议在公司会议室以现场及通讯会议的方式召开，会议通知于 2025 年 4 月 11 日以电话或邮件的形式发出。会议应出席董事 7 人，实际出席董 事 7 人，其中董事郭宝华、杨之曙、沈维涛以通讯表决方式出席，会议由董事长 杨清金先生主持，部分监事及高级管理人员列席会议。本次会议的召集、召开和 表决程序符合《公司法》《证券法》等法律法规、规范性文件和《公司章程》的 有关规定，会议合法、有效。 ...

证券代码：301565 证券简称：中仑新材 公告编号：2025-010 二、2024 年度现金分红方案的具体情况 （一） 现金分红方案不触及其他风险警示情形 中仑新材料股份有限公司 关于2024年度利润分配预案的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 中仑新材料股份有限公司（以下简称"公司"）于 2025 年 4 月 22 日召开第 二届董事会独立董事专门会议 2025 年第一次会议、第二届监事会第八次会议及 第二届董事会第八次会议，分别审议通过了《关于 2024 年度利润分配预案的议 案》，本议案尚须提交公司 2024 年度股东大会审议。现将有关情况公告如下： 一、2024 年度利润分配预案的基本情况 根据容诚会计师事务所（特殊普通合伙）出具的标准无保留审计报告，公 司2024年度合并报表归属于上市公司股东的净利润为113,150,851.81元，未分 配利润1,030,367,559.92元;母公司净利润 7,718,343.39元，未分配利润 122,849,627.96元，根据合并报表和母公司报表中未分配利润孰低原则，公司 本年度可供分配 ...

Financial Performance - The company's revenue for Q1 2025 was ¥479,424,728.19, a decrease of 15.06% compared to ¥564,434,000.38 in the same period last year[5]. - Net profit attributable to shareholders was ¥30,249,202.61, down 45.14% from ¥55,137,809.45 year-on-year[5]. - Basic earnings per share decreased by 50.00% to ¥0.08 from ¥0.16 in the same period last year[5]. - Operating profit decreased by 46.66% to ¥32,987,668.04 from ¥61,846,931.31 in the previous year[10]. - The total profit for the period was ¥32,806,246.22, down 46.94% from ¥61,827,119.54 year-on-year[10]. - Total operating revenue decreased to ¥479,424,728.19 from ¥564,434,000.38, representing a decline of approximately 15.06% year-over-year[20]. - Total operating costs decreased to ¥449,839,378.18 from ¥506,931,391.06, a reduction of about 11.25% year-over-year[20]. - Net profit for the period was ¥30,249,202.61, down from ¥55,137,809.45, indicating a decline of approximately 45.00% year-over-year[21]. - Operating profit decreased to ¥32,987,668.04 from ¥61,846,931.31, a drop of around 46.67% year-over-year[21]. - Basic and diluted earnings per share decreased to ¥0.08 from ¥0.16, a decline of 50.00% year-over-year[22]. - Other comprehensive income after tax decreased to -¥2,762,085.47 from -¥104,072.60, indicating a significant increase in losses[22]. Cash Flow and Liquidity - The net cash flow from operating activities was -¥177,767,398.49, a decline of 820.74% compared to ¥24,664,449.75 in the previous year[5]. - Cash inflow from operating activities was ¥533,994,078.25, down from ¥607,249,854.36, reflecting a decrease of about 12.06% year-over-year[24]. - The net cash flow from operating activities was -$177.77 million, a significant decrease compared to $24.66 million in the previous period, indicating a decline in operational efficiency[25]. - Cash outflows from operating activities totaled $711.76 million, up from $582.59 million, reflecting increased operational costs[25]. - The net cash flow from investing activities was -$35.90 million, an improvement from -$44.48 million, suggesting better management of investment expenditures[25]. - Cash inflows from financing activities amounted to $183.68 million, compared to $159.85 million, indicating a positive trend in financing efforts[25]. - The net cash flow from financing activities was $139.80 million, a turnaround from -$68.52 million, highlighting improved capital management[25]. - The ending cash and cash equivalents balance was $208.99 million, up from $152.16 million, showing a stronger liquidity position[25]. Assets and Liabilities - Total assets at the end of the reporting period were ¥3,493,841,632.51, a decrease of 1.61% from ¥3,550,887,708.11 at the end of the previous year[5]. - Total current assets decreased from ¥1,779,480,058.87 to ¥1,676,474,415.04, a reduction of about 5.8%[17]. - Total liabilities decreased to ¥1,119,274,684.40 from ¥1,203,807,877.14, a reduction of approximately 7.00% year-over-year[18]. - Non-current liabilities increased to ¥271,497,708.81 from ¥190,814,797.14, an increase of about 42.36% year-over-year[18]. - The total liabilities include accounts payable of ¥639,345,260.00, down from ¥767,789,516.20, a decrease of approximately 16.7%[17]. - The company has a goodwill of ¥5,830,005.27, unchanged from the previous period[17]. - Total equity attributable to shareholders increased to ¥2,374,566,948.11 from ¥2,347,079,830.97, an increase of approximately 1.17% year-over-year[18]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 19,385[12]. - The largest shareholder, Zhonglun Technology Group, holds 52.27% of the voting rights, equating to 209,100,000 shares[12]. Inventory and Borrowings - The company reported a significant increase in inventory, which rose by 37.55% to ¥447,394,478.74 from ¥325,251,963.75[10]. - The company's long-term borrowings increased by 55.94% to ¥225,365,982.61, up from ¥144,519,372.28[10]. - Inventory increased significantly from ¥325,251,963.75 to ¥447,394,478.74, representing a growth of approximately 37.5%[17]. Future Plans - The company plans to expand its market presence and invest in new product development[13]. - There are no changes in the top 10 shareholders' participation in margin trading or securities lending[13].

Financial Performance - The company's operating revenue for 2024 was ¥2,473,261,225.51, representing a 5.14% increase compared to ¥2,352,273,918.49 in 2023[17]. - The net profit attributable to shareholders decreased by 45.13% to ¥113,150,851.81 in 2024 from ¥206,203,613.50 in 2023[17]. - The basic earnings per share dropped by 49.18% to ¥0.31 in 2024, down from ¥0.61 in 2023[17]. - Total assets increased by 24.34% to ¥3,550,887,708.11 at the end of 2024, compared to ¥2,855,735,925.35 at the end of 2023[17]. - The company's net assets attributable to shareholders rose by 46.70% to ¥2,347,079,830.97 at the end of 2024, up from ¥1,599,867,106.73 at the end of 2023[17]. - Cash flow from operating activities decreased by 8.23% to ¥341,455,624.85 in 2024, compared to ¥372,072,014.28 in 2023[17]. - The company reported a significant decline in net profit after deducting non-recurring gains and losses, which fell by 48.18% to ¥104,222,533.62 in 2024 from ¥201,134,612.49 in 2023[17]. - The gross profit margin for membrane materials was reported at 14.14%, a decrease of 7.03% compared to the previous year[73]. - Net profit attributable to shareholders was 11,315.09 million yuan, a decrease of 45.13% year-on-year, while net profit after deducting non-recurring gains and losses was 10,422.25 million yuan, down 48.18%[63]. Investment and Capital Expenditure - The company plans to invest CNY 2.5 billion in a new energy membrane project, aiming to enhance its high-end product matrix and industry competitiveness[69]. - The company is constructing a functional BOPA film production line with a capacity of 90,000 tons/year, funded by self-owned capital, and plans to build two additional lines with a total capacity of 60,000 tons[52]. - The company has a designed capacity of 145,000 tons/year for PA6, with a capacity utilization rate of 101.38%[53]. - The company has a total of 14,000 tons/year of PA6 capacity currently under construction, with progress detailed in the financial report[53]. - The company reported a total investment of 32.95 million in new energy membrane projects, with a cumulative investment of 139.6 million by the end of the reporting period[104]. - The self-funded investment in the BOPA film project in Indonesia was 2.089 million, with a total investment of 70.21 million, indicating ongoing construction[104]. Research and Development - R&D expenses reached 8,333.28 million yuan in 2024, an increase of 8.23% year-on-year, with a total of 216 patents held, including 95 invention patents[66]. - The company is developing several key projects, including low-carbon high-strength biaxially oriented polyamide films and ultra-thin capacitor polypropylene films, in line with national "dual carbon" policies[66]. - The company aims to enhance its R&D capabilities by attracting high-level talent and investing in new product development to maintain its industry leadership[136]. - The company has invested approximately 230 million yuan in research and development over the past three years, emphasizing the importance of continuous innovation to maintain technological leadership in the new materials sector[198]. - The company plans to conduct a total of 288 training courses in 2024, including 21 for research and development[194]. Market Position and Strategy - The company holds a leading position in the functional BOPA film market, with a global market share of 20% and a domestic market share of 36% from 2021 to 2023[31]. - The company is actively expanding its market presence in Southeast Asia through the construction of a production base in Indonesia, with two production lines planned for 2025 and 2026[70]. - The company has established a strategic customer network, including partnerships with major brands like COFCO Group and Unilever, enhancing its market presence[61]. - The company plans to enhance its technological innovation capabilities and develop new products, aiming to increase overall market share and industry influence by 2025[130]. - The company is focused on sustainable development and aims to create a "membrane industry ecosystem" that integrates upstream materials and downstream applications[129]. Governance and Compliance - All board members attended the meeting to review the annual report, ensuring accountability for its accuracy[3]. - The company emphasizes investor relations management, providing transparent communication channels for investors[149]. - The company held 1 annual general meeting and 1 extraordinary general meeting during the reporting period, ensuring compliance with legal requirements and protecting shareholders' rights[142]. - The second board of directors was successfully elected in April 2024, consisting of 7 members, including 3 independent directors, meeting regulatory requirements[144]. - The company has established a management system for forward foreign exchange trading to control transaction risks effectively[107]. Risk Management - The company emphasizes the importance of risk awareness regarding future plans and performance forecasts[3]. - The company has not identified any significant risks that could materially impact its operations during the reporting period[3]. - The company faces risks from raw material price fluctuations, particularly due to its reliance on caprolactam, which is affected by international crude oil prices[134]. - The company’s BOPA film business operates in over 40 countries, with sales primarily in USD, making it vulnerable to exchange rate fluctuations[134]. - The company’s risk management measures for foreign exchange derivatives include strict adherence to hedging principles and avoiding speculative trading[107]. Environmental and Social Responsibility - The company’s biodegradable BOPLA films are positioned to benefit from global trends towards environmentally friendly materials and related policies[32]. - The production of biodegradable BOPLA films supports national "carbon neutrality" policies, reducing environmental impact[51]. - The company actively respects and protects the rights of stakeholders, focusing on environmental protection and social responsibility[150]. - The BOPA film industry is experiencing a trend towards green development, with increasing demand driven by consumer upgrades and the rapid growth of the new energy vehicle industry[127]. Shareholder Relations - The company plans to explore diversified dividend methods to provide better returns to all shareholders[198]. - The cash dividend policy was designed to balance short-term shareholder returns with long-term value creation, considering the company's industry characteristics and funding needs[198]. - The company has established convenient measures for minority shareholders to participate in cash dividend decisions, in compliance with regulatory requirements[198]. - The company aims to strengthen communication with investors through various channels, including performance briefings and investor calls[198].

证券代码：301565 证券简称：中仑新材 公告编号：2025-004 中仑新材料股份有限公司 第二届董事会第七次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 一、董事会会议召开情况 2025 年 3 月 24 日，中仑新材料股份有限公司（以下简称"公司"）第二届 董事会第七次会议在公司会议室以现场及通讯会议的方式召开，会议通知于 2025 年 3 月 21 日以电话、邮件的形式发出。会议应出席董事 7 人，实际出席董 事 7 人，其中董事郭宝华、杨之曙、沈维涛以通讯表决方式出席，会议由董事长 杨清金先生主持，部分监事及高级管理人员列席会议。本次会议的召开符合相关 法律法规和《公司章程》规定。 二、董事会会议审议情况 1、审议通过《关于聘任董事会秘书的议案》 经公司董事长杨清金先生提名，董事会提名委员会资格审查通过，董事会同 意聘任马彬惠女士担任公司董事会秘书，任期自本次董事会审议通过之日起至第 二届董事会届满之日止，即至 2027 年 4 月 21 日止。 马彬惠女士目前在公司担任证券中心总监、证券事务代表职务，已取得深圳 证券交易所上市公司 ...